Showing results (631-640 of 1,502) with videos related to

Sort By:
Pageof 151
Familial Cancer|December 25, 2015
Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defectIngrid P Vogelaar, Marjolijn J L Ligtenberg, Rachel S van der Post, et al.
Familial Cancer|January 3, 2016
Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancerRosa Murria Estal, Sarai Palanca Suela, Inmaculada de Juan Jiménez, et al.
Familial Cancer|August 8, 2015
POLE mutations in families predisposed to cutaneous melanomaLauren G Aoude, Ellen Heitzer, Peter Johansson, et al.
Familial Cancer|February 3, 2016
Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosisRenaud Sabatier, Elise Lavit, Jessica Moretta, et al.
Familial Cancer|February 3, 2016
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish populationHenriette Roed Nielsen, Mef Nilbert, Janne Petersen, et al.
Familial Cancer|February 4, 2016
Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologiesMasakazu Kohda, Kensuke Kumamoto, Hidetaka Eguchi, et al.
Familial Cancer|February 17, 2016
Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriersZ Ghorbanoghli, M H Nieuwenhuis, J J Houwing-Duistermaat, et al.
Familial Cancer|February 28, 2016
MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristicsJessica Oliboni Scapineli, Lucieli Ceolin, Márcia Khaled Puñales, et al.
Familial Cancer|August 29, 2015
Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjectsCamelia Abdel-Malak, Hossam Darwish, Afaf Elsaid, et al.
Familial Cancer|August 16, 2015
Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patientsDaniel Robert Quast, Ralph Schneider, Emanuel Burdzik, et al.
Pageof 151